Table 5 Numbers of near-fatala overdose experiences ever and near-fatal overdose experiences through current co-use pattern and opioid agonist therapy (OAT) taken
From: A qualitative study of benzodiazepine/z-drug and opioid co-use patterns and overdose risk
No pattern reportedb (n = 5) | Co-use to aid sleep or come down (n = 3) | Curated co-use (n = 2) | Morning and evening BZ/Z doses with OP throughout the day (n = 4) | Co-use binges (n = 13) | Co-use throughout the day (n = 14) | BZ/Z use throughout the day, OAT only no other OP (n = 7) | |
|---|---|---|---|---|---|---|---|
Number of participants who had ever had a near-fatal overdose experiencea | 3 (OAT prescribed at time of this OD methadone n = 2, buprenorphine n = 1) | 2 | 2 | 2 | 11 | 12 | 5 |
Number of participants who had a near-fatal overdosea using their current co-use pattern (OAT prescribed at time of this OD) | n/a | 1 (methadone n = 1) | 1 (buprenorphine n = 1) | 2 (methadone n = 2) | 9 (methadone, n = 6, buprenorphine n = 1) | 9 (methadone, n = 5, buprenorphine n = 1) | 5 (methadone, n = 3, buprenorphine n = 2) |